Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
Francis J Zamora,1,2 Ellen Dowers,2 Faiza Yasin,3 Onyema Ogbuagu3 1Department of Pharmacy Services, Broward Health Medical Center, Fort Lauderdale, FL, USA; 2Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 3Section of Infectious Diseases, Yale AIDS Program, Yale Univers...
Saved in:
Main Authors: | Zamora FJ, Dowers E, Yasin F, Ogbuagu O |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/134e70daf0d848d3b33efb2378bc5b49 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
by: Dowers E, et al.
Published: (2018) -
EXPERIENCE WITH DOLUTEGRAVIR IN HIV PATIENTS AT A PUBLIC SECTOR HOSPITAL IN KARACHI, PAKISTAN
by: Farzana Batool, et al.
Published: (2021) -
Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
by: Navarro J, et al.
Published: (2016) -
Effect of Lamivudine on the Rat Pregnancy Outcome
by: Pontes,Rosana Dorsa Vieira, et al.
Published: (2005) -
Antiretroviral therapy interruptions: impact on HIV treatment and transmission
by: Dubrocq G, et al.
Published: (2018)